Non-motor Effects of Bemdaneprocel for Parkinson’s Disease: 18-month Results from a Phase 1 Study (P9-3.001)
Harini Sarva(Cornell University), Viviane Tabar(Memorial Sloan Kettering Cancer Center), Suneil K. Kalia(University Health Network), Michele K. York(Baylor College of Medicine), Ahmed Enayetallah, Andrés M. Lozano(University of Toronto), Antoine Lampron, Claire Henchcliffe(University of California, Irvine), Cameron Brennan(Memorial Sloan Kettering Cancer Center), Whitney Stemple, Marcus Yountz, Nauman Abid, Kenny Yu(Memorial Sloan Kettering Cancer Center)
Cited by 0
Related Papers
The Somatic Genomic Landscape of Glioblastoma
|Cell|2013|5.2k
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
|Nature Genetics|2019|4.4k
Deep Brain Stimulation for Treatment-Resistant Depression
|Neuron|2005|4.1k
Molecular characterization of the tumor microenvironment in breast cancer
|Cancer Cell|2004|1.3k
Subcallosal Cingulate Gyrus Deep Brain Stimulation for Treatment-Resistant Depression
|Biological Psychiatry|2008|1k